{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:47:55Z","timestamp":1785610075081,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jneuroim.2013.01.011","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T11:27:40Z","timestamp":1361273260000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome"],"prefix":"10.1016","volume":"257","author":[{"given":"Diana","family":"Ferraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vitetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Federzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Frigio","family":"Nichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.01.011_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"Bosc\u00e1","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0015","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0020","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome PreCISe study: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","article-title":"Natural history of multiple sclerosis: a unifying concept","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1352458511424589","article-title":"Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual","volume":"18","author":"Durante","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb9000","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1468-1331.2008.02504.x","article-title":"Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment","volume":"16","author":"Garc\u00eda-Barrag\u00e1n","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1352458510385506","article-title":"Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event","volume":"17","author":"Gout","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0050","first-page":"154","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis","volume":"131","author":"Jacobs","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000103643","article-title":"Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis","volume":"58","author":"Jongen","year":"2007","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0060","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0021-9681(77)90010-8","article-title":"Studies on the natural history of multiple sclerosis \u2014 8. Early prognostic features of the later course of the illness","volume":"30","author":"Kurtzke","year":"1977","journal-title":"J. Chronobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0070","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awq076","article-title":"Evidence for a two-stage disability progression in multiple sclerosis","volume":"133","author":"Leray","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00234-011-0841-7","article-title":"Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes","volume":"54","author":"Magraner","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00415-008-0827-5","article-title":"A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease","volume":"255","author":"Mandrioli","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.168.1.458","article-title":"The membrane attack complex of complement causes severe demyelination associated with acute axonal injury","volume":"168","author":"Mead","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/brain\/116.1.135","article-title":"The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study","volume":"116","author":"Morrissey","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","article-title":"The prognostic value of brain MRI in clinically isolated syndromes of the CNS: a 10year follow-up","volume":"121","author":"O'Riordan","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0105","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis","volume":"65","author":"Optic Neuritis Study group","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp.2005.086116","article-title":"Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis","volume":"77","author":"Perini","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-007-0733-2","article-title":"Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b","volume":"255","author":"Polman","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1007021916210","article-title":"Antibody-mediated CNS demyelination: focal spinal cord lesions induced by implantation of an IgM anti-galactocerebroside-secreting hybridoma","volume":"28","author":"Rosenbluth","year":"1999","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/B:NEUR.0000010085.91976.a6","article-title":"Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma","volume":"32","author":"Rosenbluth","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458510386999","article-title":"Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome","volume":"17","author":"Ruet","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0140","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(94)90329-8","article-title":"Occurrence of oligoclonal IgM bands in the cerebrospinal fluid of neurological patients: an immunoaffinity-mediated capillary blot study","volume":"124","author":"Sindic","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1352458510386996","article-title":"Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM","volume":"17","author":"Sola","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/jnnp.2006.090910","article-title":"Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison","volume":"77","author":"Swanton","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0160","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/1352458508095729","article-title":"Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis","volume":"14","author":"Thangarajh","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.20363","article-title":"Is optic neuritis more benign than other first attacks in multiple sclerosis?","volume":"57","author":"Tintor\u00e9","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0170","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000237354.10144.ec","article-title":"Baseline MRI predicts future attacks and disability in clinically isolated syndromes","volume":"67","author":"Tintor\u00e9","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0175","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintor\u00e9","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-1759(01)00492-6","article-title":"A sensitive and reproducible method for the detection of oligoclonal IgM bands","volume":"258","author":"Villar","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0190","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.58.5.824","article-title":"Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS","volume":"58","author":"Villar","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.59.4.555","article-title":"Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS","volume":"59","author":"Villar","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.10441","article-title":"Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis","volume":"53","author":"Villar","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI22833","article-title":"Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS","volume":"115","author":"Villar","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.01.011_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1352458507082046","article-title":"Influence of oligoclonal IgM specificity in multiple sclerosis disease course","volume":"14","author":"Villar","year":"2008","journal-title":"Mult. Scler."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:20:46Z","timestamp":1759047646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165572813000258"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}